Literature DB >> 6142774

Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine.

H Tsuda, T Sakata, T Masui, K Imaida, N Ito.   

Abstract

Studies were made on the effects of butylated hydroxyanisole (BHA), ethoxyquin (EQ) and acetaminophen (AAP) on the induction of neoplastic lesions in the liver and kidney of rats initiated by N-ethyl-N-hydroxyethylnitrosamine (EHEN). The number and area of histochemical gamma-glutamyltranspeptidase-positive (gamma-GT+) foci per unit area of liver section in rats given BHA, EQ or AAP were significantly less than in rats given EHEN alone. Similarly, the number of hyperplastic nodules (HN) in groups given BHA or AAP and their area in groups given BHA, EQ or AAP were significantly less than in control groups. Induction of hepatocellular carcinoma (HCC) was also clearly inhibited by these three chemicals. No liver lesions were found in any animals given BHA, EQ or AAP orally without EHEN. In contrast, the incidence and quantitative values of preneoplastic lesions and renal cell adenoma were significantly increased in groups given BHA, EQ or AAP. The results clearly demonstrated that BHA, EQ and AAP inhibited the development of gamma-GT+ foci, HN and HCC, whereas they enhanced the appearance of preneoplastic and neoplastic lesions in the kidney.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142774     DOI: 10.1093/carcin/5.4.525

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  In vitro modulation of antioxidant enzymes in normal and malignant renal epithelium.

Authors:  A H Yang; T D Oberley; L W Oberley; S M Schmid; K B Cummings
Journal:  In Vitro Cell Dev Biol       Date:  1987-08

2.  Elevated concentrations of the beta-subunit of S100 protein in renal cell tumors in rats.

Authors:  M Takashi; T Sakata; Y Nakano; Y Yamada; K Miyake; K Kato
Journal:  Urol Res       Date:  1994

Review 3.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies.

Authors:  Toni K Choueiri; Youjin Je; Eunyoung Cho
Journal:  Int J Cancer       Date:  2013-09-23       Impact factor: 7.396

5.  Hepatotoxicity of chronic high dose administration of acetaminophen to mice. A critical review and implications for hazard assessment.

Authors:  H Maruyama; G M Williams
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

6.  Regular use of analgesics is a risk factor for renal cell carcinoma.

Authors:  M Gago-Dominguez; J M Yuan; J E Castelao; R K Ross; M C Yu
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses.

Authors:  R Hasegawa; D Tiwawech; M Hirose; K Takaba; T Hoshiya; T Shirai; N Ito
Journal:  Jpn J Cancer Res       Date:  1992-05

8.  Enhancing potential of 6 different carcinogens on multi-organ tumorigenesis after initial treatment with N-methyl-N-nitrosourea in rats.

Authors:  S Uwagawa; H Tsuda; T Inoue; Y Tagawa; T Aoki; M Kagawa; T Ogiso; N Ito
Journal:  Jpn J Cancer Res       Date:  1991-12

9.  Synergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liver.

Authors:  R Hasegawa; M Mutai; K Imaida; H Tsuda; S Yamaguchi; N Ito
Journal:  Jpn J Cancer Res       Date:  1989-10

10.  Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats.

Authors:  H Tsuda; K Ozaki; S Uwagawa; S Yamaguchi; K Hakoi; T Aoki; T Kato; K Sato; N Ito
Journal:  Jpn J Cancer Res       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.